PUBLISHER: The Business Research Company | PRODUCT CODE: 1942673
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942673
A dental hemostat is a specialized surgical tool used in dental procedures to control bleeding by clamping blood vessels or tissues. It features a locking mechanism and slender, either curved or straight jaws, allowing precise manipulation during oral surgeries. This instrument helps practitioners maintain a clear field of view and improves procedural efficiency by effectively managing bleeding.
The main types of dental hemostats include pads, gels, sponges, liquids, and powders. Pads, also referred to as sheet or gauze-based hemostats, are thin and flexible materials designed to stop bleeding. These products are made from various substances such as collagen, chemical agents, gelatin, cellulose, and others. They are utilized in applications like oral surgery, periodontics, endodontics, implantology, and more. Key end users include dental clinics, hospitals, dental schools, research laboratories, and other related institutions.
Tariffs have influenced the dental hemostat market by raising costs for imported surgical instruments and raw materials, including collagen, gelatin, and chemical reagents. Segments such as collagen-based pads, gelatin sponges, and polymer gels are particularly affected, with Asia-Pacific regions like China and India facing higher import duties. This has led to increased procurement costs and supply chain adjustments for dental clinics and hospitals. On the positive side, tariffs encourage local manufacturing, innovation in alternative biomaterials, and investment in domestic production capabilities.
The dental hemostat market research report is one of a series of new reports from The Business Research Company that provides dental hemostat market statistics, including dental hemostat industry global market size, regional shares, competitors with a dental hemostat market share, detailed dental hemostat market segments, market trends and opportunities, and any further data you may need to thrive in the dental hemostat industry. This dental hemostat market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The dental hemostat market size has grown strongly in recent years. It will grow from $1.79 billion in 2025 to $1.91 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to reliance on traditional cellulose and chemical hemostats, limited availability of advanced biomaterials, increasing oral surgical procedures, growth of dental clinics and hospitals, rising awareness about bleeding control in dentistry.
The dental hemostat market size is expected to see strong growth in the next few years. It will grow to $2.47 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to development of collagen and chitosan-based advanced hemostats, expansion of implantology and periodontal procedures, increasing dental research and training, adoption of minimally invasive dental techniques, rising demand for multi-form hemostatic products (pads, gels, sponges, powders. Major trends in the forecast period include rising demand for collagen and gelatin-based hemostats, increased use of biocompatible and plant-derived materials, expansion of hemostat applications in implantology and endodontics, adoption of advanced delivery forms like pads, gels, and powders, growing focus on sterilization, safety, and regulatory compliance.
The increase in dental care spending is expected to drive the growth of the dental hemostat market in the coming years. Dental care spending refers to the total amount of money allocated to oral health services, including clinical treatments, surgical procedures, and preventive care. Spending on dental care is rising as modern practices invest in advanced technologies that improve treatment precision and patient comfort, which also tends to raise service costs. Higher dental care spending leads to greater demand for advanced surgical treatments, increasing the use of dental hemostats to control bleeding and enhance outcomes. As more patients pursue quality dental care, dental professionals rely on effective hemostatic products to promote quicker recovery and minimize complications. For example, in December 2024, the American Dental Association, a US-based professional organization, reported that US dental spending rose by $4 billion (2.5%) in 2023 compared to 2022, reaching $174 billion and accounting for 3.6% of total health expenditures, largely driven by increased Medicare dental spending. Therefore, the rise in dental care spending is supporting the expansion of the dental hemostat market.
Leading companies in the dental hemostat market are concentrating on developing advanced technologies like hydrogel polymer sponges to enhance post-extraction care. A hydrogel polymer sponge is a flexible, highly absorbent material made from crosslinked hydrophilic polymers, commonly used in biomedical applications for its water-retention capabilities. For instance, in September 2024, Toagosei Co. Ltd., a chemical company based in Japan, launched Aron Cure Dental, a next-generation dental hemostatic agent designed specifically for tooth extraction sites. This innovative product incorporates a hydrogel polymer sponge that adheres to tissue, effectively stops bleeding without compression or removal, and naturally dissolves in saliva. Classified as a Class III medical device, it utilizes Wispec's hydrogel technology to significantly shorten treatment time, reduce the workload for dental professionals, and support better gum healing by securely maintaining blood clots.
In February 2025, Premier Dental Products, a US-based dental hemostat manufacturer, formed a partnership with Radial Equity Partners to accelerate its growth and innovation, enhance its commercial capabilities, and support its goal of becoming a leading player in the dental industry. Radial Equity Partners is a private equity firm based in the United States.
Major companies operating in the dental hemostat market are 3M Company, Medline Industries LP, Teleflex Incorporated, Patterson Dental Supply, Hu Friedy, Integra LifeSciences Corporation, B Braun Melsungen AG, Advanced Medical Solutions Plc, Premier Dental Co, Asa Dental, PDT Inc, DoWell Dental Products Inc, Fine Science Tools Inc, Nordent Mfg Inc, Shanghai Medical Instruments Co Ltd, Quala, Septodont Holding SAS, Ultradent Products Inc, Pulpdent Corporation, DenMat Holdings LLC, COLTENE Group, Kerr Corporation
North America was the largest region in the dental hemostat market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dental hemostat market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the dental hemostat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The dental hemostat market consists of sales of curved hemostats, micro hemostats, pediatric hemostats, and disposable hemostats. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Dental Hemostat Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses dental hemostat market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for dental hemostat ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dental hemostat market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.